NCT04236609

Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global

CompletedNAINTERVENTIONAL

Trial Details

Start: 2020-06-15Est. Completion: 2023-11-30

Enrollment target: 3,050 participants

Locations

The Prince Charles Hospital, Chermside, Australia
St Vincent Hospital, Melbourne, Australia
The Wollongong Hospital, Wollongong, Australia
University Heart Center Graz, Graz, Austria
Kardinal Schwarzenberg Klinikum, Schwarzach im Pongau, Austria
National Heart Foundation Hospital & Research Institute, Dhaka, Bangladesh
Antwerp Cardiovascular Center Middelheim, Antwerp, Belgium
UZ Leuven, Leuven, Belgium
Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil
INSTITUTO DO CORAÇÃO - InCor University of São Paulo Medical School, São Paulo, Brazil
University Hospital Brno, Department of Medecine Cardiology, Brno, Czechia
University Hospital Královské Vinohrady, Department of Medecine Cardiology, Prague, Czechia
Clinique Axium, Aix-en-Provence, France
CHRU Brest, Brest, France
Clinique de Fontaine, Fontaine-lès-Dijon, France
Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France
Hôpital La Timone, Service Cardiologie, Marseille, France

Heart Failure

Background: More than 6.5 million people in the United States live with heart failure (HF), and more than a million new…

Baltimore, United StatesCompleted Apr 30, 2028

Type 1 Diabetes MellitusType 2 Diabetes Mellitus

This is an open label, two-arm, randomized multi-center clinical device study in adult subjects with Type 1 diabetes (T1…

Gdansk, PolandEst. completion Nov 15, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.